George A. Moniz
10Patents
3h-index
46Co-inventors
56Inventor score
Filing activity: May 24, 2005 → Dec 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7253196B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 10 | Expired |
| US7807700B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 8 | Active |
| US9416109B2 | Methods and compounds useful in the synthesis of orexin-2 receptor antagonists | Chemistry; Metallurgy | 5 | Active |
| US8686011B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 3 | Active |
| US8541592B2 | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 | Chemistry; Metallurgy | 3 | Active |
| US8541593B2 | Process for making substituted 2-amino-thiazolones | Human Necessities | 0 | Active |
| US9828336B2 | Methods and compounds useful in the synthesis of orexin-2 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US11498916B2 | Crystalline FGFR4 inhibitor compound and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8536345B2 | Process for making substituted 2-amino-thiazolones | Chemistry; Metallurgy | 0 | Active |
| US10562888B2 | Crystalline FGFR4 inhibitor compound and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.